| Machine learning classifies cancer D Wong, S Yip Nature 555 (7697), 446-447, 2018 | 93 | 2018 |
| Methods for identifying patients with tropomyosin receptor kinase (TRK) fusion cancer D Wong, S Yip, PH Sorensen Pathology & Oncology Research 26, 1385-1399, 2020 | 45 | 2020 |
| Transcriptomic analysis of CIC and ATXN1L reveal a functional relationship exploited by cancer D Wong, K Lounsbury, A Lum, J Song, S Chan, V LeBlanc, S Chittaranjan, ... Oncogene 38 (2), 273-290, 2019 | 37 | 2019 |
| Making heads or tails – the emergence of capicua (CIC) as an important multifunctional tumour suppressor D Wong, S Yip The Journal of pathology 250 (5), 532-540, 2020 | 27 | 2020 |
| Characterisation of isocitrate dehydrogenase 1/isocitrate dehydrogenase 2 gene mutation and the d‐2‐hydroxyglutarate oncometabolite level in dedifferentiated … N Mohammad, D Wong, A Lum, J Lin, J Ho, CH Lee, S Yip Histopathology 76 (5), 722-730, 2020 | 23 | 2020 |
| HDAC2 regulates site-specific acetylation of MDM2 and its ubiquitination signaling in tumor suppression N Patel, J Wang, K Shiozawa, KB Jones, Y Zhang, JW Prokop, ... Iscience 13, 43-54, 2019 | 13 | 2019 |
| TRIM25 promotes Capicua degradation independently of ERK in the absence of ATXN1L D Wong, L Sogerer, SS Lee, V Wong, A Lum, AB Levine, MA Marra, S Yip BMC biology 18, 1-17, 2020 | 10 | 2020 |
| Finding a four-leaf clover—identifying long-term survivors in IDH-wildtype glioblastoma D Wong, S Yip Neuro-oncology 21 (11), 1352-1353, 2019 | 8 | 2019 |
| Early Cancer Detection in Li–Fraumeni Syndrome with Cell-Free DNA D Wong, P Luo, LE Oldfield, H Gong, L Brunga, R Rabinowicz, V Subasri, ... Cancer Discovery 14 (1), 104-119, 2024 | 6 | 2024 |
| Ependymoma and chordoma AB Levine, D Wong, M Fatehi, S Yip Neurosurgery 87 (5), 860-870, 2020 | 6 | 2020 |
| Identifying mechanisms of resistance by circulating tumor DNA in EVOLVE, a phase II trial of cediranib plus olaparib for ovarian cancer at time of PARP inhibitor progression S Lheureux, SD Prokopec, LE Oldfield, E Gonzalez-Ochoa, JP Bruce, ... Clinical Cancer Research 29 (18), 3706-3716, 2023 | 5 | 2023 |
| Integrated proteomic analysis of low-grade gliomas reveals contributions of 1p-19q co-deletion to oligodendroglioma D Wong, TH Lee, A Lum, VL Tao, S Yip Acta Neuropathologica Communications 10 (1), 70, 2022 | 5 | 2022 |
| Integrated, longitudinal analysis of cell-free DNA in uveal melanoma D Wong, P Luo, N Znassi, DP Arteaga, D Gray, A Danesh, M Han, ... Cancer Research Communications 3 (2), 267-280, 2023 | 4 | 2023 |
| The pivotal role of sampling recurrent tumors in the precision care of patients with tumors of the central nervous system D Wong, Y Shen, AB Levine, E Pleasance, M Jones, K Mungall, ... Molecular Case Studies 5 (4), a004143, 2019 | 4 | 2019 |
| Pathology of primary brain tumors—gliomas D Wong, S Yip Comprehensive Overview of Modern Surgical Approaches to Intrinsic Brain …, 2019 | 4 | 2019 |
| Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsy KM Farncombe, D Wong, ML Norman, LE Oldfield, JA Sobotka, M Basik, ... The American Journal of Human Genetics 110 (10), 1616-1627, 2023 | 1 | 2023 |
| Early changes in tumor-naive cell-free methylomes and fragmentomes predict outcomes in pembrolizumab-treated solid tumors EY Stutheit-Zhao, E Sanz-Garcia, Z Liu, D Wong, K Marsh, ... Cancer Discovery, 2024 | | 2024 |
| Characterization of IDH1/IDH2 Mutation and D-2-Hydroxyglutarate Oncometabolite Level in Dedifferentiated Chondrosarcoma N Mohammad, A Lum, J Lin, D Wong, J Ho, CH Lee, T Ng, S Yip LABORATORY INVESTIGATION 98, 34-34, 2018 | | 2018 |
| PATH-42. DIAGNOSIS AND PROGNOSTICATION OF AN ATYPICAL ADULT PRESENTATION OF DIFFUSE LEPTOMENINGEAL GLIONEURONAL TUMOR (DLGNT) BY METHYLATION PROFILING C Kubelt, B Brändl, A van Bömmel, C Rohrandt, G Wang, M Evers, ... Neuro-oncology, 2000 | | 2000 |
Stephen YipVancouver General Hospital/BC Cancer/BCGSCVerified email at vch.ca
